Hawkeye Bio Overview
- Founded
-
2018
- Status
-
Private
- Employees
-
6
- Latest Deal Type
-
Early Stage VC
- Investors
-
2
Hawkeye Bio General Information
Description
Developer of a non-invasive breath test system designed for the detection of lung cancer at all stages of the disease. The company's patented and clinically validated test system identifies changes in gene expression ratios and detects any symptoms of cancer in the human body, enabling the healthcare industry to improve survival rates and lower costs of treatment.
Contact Information
Website
www.hawkeyebio.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Diagnostic Equipment
Primary Office
- 1124 West Carson Street
- MRL Building, 3rd Floor
- Torrance, CA 90502
- United States
Hawkeye Bio Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Early Stage VC | 01-Jan-2020 | Completed | Startup | |||
| 1. Grant | 27-Jun-2019 | Completed | Startup |
Hawkeye Bio Executive Team (4)
Hawkeye Bio Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Hawkeye Bio Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| NJF Capital | Venture Capital | Minority | 000 0000 | 000000 0 | |
| Johnson & Johnson Innovation - JLABS | Accelerator/Incubator | 000 0000 | 000000 0 |